HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Free Full Text Full Text (PDF) Link to related articles Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Renehan, A. G Articles by Howell, A. Search for Related Content PubMed PubMed Citation Articles by Renehan, A. G Articles by Howell, A.

¹ Department of Surgery and
² Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK

(Requests for offprints should be addressed to A Renehan; Email: arenehan{at}picr.man.ac.uk)

Insulin-like growth factor (IGF)-I, and its main binding protein, IGFBP-3, are multi-functional regulatory peptides of cell growth and survival, attributes important for tumourigenesis. Following seminal work published in 1998, it has been hypothesised that circulating concentrations of these growth factors may be associated with cancer risk. Systematic reviews have reported that high normal range circulating levels of total IGF-I predict for pre- but not post-menopausal breast cancer. By contrast, associations with circulating IGFBP-3 have been inconsistent. A cumulative meta-analysis demonstrates that earlier reported positive associations between IGFBP-3 and pre-menopausal breast cancer risk now seem less clear as large-size cohorts are published. The reasons are complex and include differences in study design, lack of standardisation between assays, and variations in IGFBP-3 proteolytic activity – these are discussed in this commentary.

This article has been cited by other articles:

				J. H Fowke, C. E Matthews, H. Yu, Q. Cai, S. Cohen, M. S Buchowski, W. Zheng, and W. J Blot Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3 Endocr. Relat. Cancer, March 1, 2010; 17(1): 51 - 60. [Abstract] [Full Text] [PDF]

				K. Walker, O. Fletcher, N. Johnson, B. Coupland, V. A. McCormack, E. Folkerd, L. Gibson, S. G. Hillier, J. M. Holly, S. Moss, et al. Premenopausal Mammographic Density in Relation to Cyclic Variations in Endogenous Sex Hormone Levels, Prolactin, and Insulin-like Growth Factors Cancer Res., August 15, 2009; 69(16): 6490 - 6499. [Abstract] [Full Text] [PDF]

				F. L. Crowe, T. J. Key, N. E. Allen, P. N. Appleby, A. Roddam, K. Overvad, H. Gronbaek, A. Tjonneland, J. Halkjaer, L. Dossus, et al. The Association between Diet and Serum Concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1333 - 1340. [Abstract] [Full Text] [PDF]

				D. L. Kleinberg, T. L. Wood, P. A. Furth, and A. V. Lee Growth Hormone and Insulin-Like Growth Factor-I in the Transition from Normal Mammary Development to Preneoplastic Mammary Lesions Endocr. Rev., February 1, 2009; 30(1): 51 - 74. [Abstract] [Full Text] [PDF]

				Y. Kim, S. K. Park, W. Han, D.-H. Kim, Y.-C. Hong, E. H. Ha, S.-H. Ahn, D.-Y. Noh, D. Kang, and K.-Y. Yoo Serum High-Density Lipoprotein Cholesterol and Breast Cancer Risk by Menopausal Status, Body Mass Index, and Hormonal Receptor in Korea Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 508 - 515. [Abstract] [Full Text] [PDF]

				N. K. Saxena, L. Taliaferro-Smith, B. B. Knight, D. Merlin, F. A. Anania, R. M. O'Regan, and D. Sharma Bidirectional Crosstalk between Leptin and Insulin-like Growth Factor-I Signaling Promotes Invasion and Migration of Breast Cancer Cells via Transactivation of Epidermal Growth Factor Receptor Cancer Res., December 1, 2008; 68(23): 9712 - 9722. [Abstract] [Full Text] [PDF]

				K. K. de Ostrovich, I. Lambertz, J. K. L. Colby, J. Tian, J. E. Rundhaug, D. Johnston, C. J. Conti, J. DiGiovanni, and R. Fuchs-Young Paracrine Overexpression of Insulin-Like Growth Factor-1 Enhances Mammary Tumorigenesis in Vivo Am. J. Pathol., September 1, 2008; 173(3): 824 - 834. [Abstract] [Full Text] [PDF]

				H. G Mulholland, L. J Murray, and M. M Cantwell Glycemic index, glycemic load, and chronic disease risk Am. J. Clinical Nutrition, August 1, 2008; 88(2): 475 - 476. [Full Text] [PDF]

				L. J. Vatten, J. M. Holly, D. Gunnell, and S. Tretli Nested Case-Control Study of the Association of Circulating Levels of Serum Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 with Breast Cancer in Young Women in Norway Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2097 - 2100. [Abstract] [Full Text] [PDF]

				T. V. Nguyen, A. E. Nelson, C. J. Howe, M. J. Seibel, R. C. Baxter, D. J. Handelsman, R. Kazlauskas, and K. K. Ho Within-Subject Variability and Analytic Imprecision of Insulinlike Growth Factor Axis and Collagen Markers: Implications for Clinical Diagnosis and Doping Tests Clin. Chem., August 1, 2008; 54(8): 1268 - 1276. [Abstract] [Full Text] [PDF]

				B. J. Fuhrman, B. E. Teter, M. Barba, C. Byrne, A. Cavalleri, B. J. Grant, P. J. Horvath, D. Morelli, E. Venturelli, and P. C. Muti Equol Status Modifies the Association of Soy Intake and Mammographic Density in a Sample of Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 33 - 42. [Abstract] [Full Text] [PDF]

				J. C van der Pols, C. Bain, D. Gunnell, G. Davey Smith, C. Frobisher, and R. M Martin Childhood dairy intake and adult cancer risk: 65-y follow-up of the Boyd Orr cohort Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1722 - 1729. [Abstract] [Full Text] [PDF]

				J. Paquette, B. Bessette, E. Ledru, and C. Deal Identification of Upstream Stimulatory Factor Binding Sites in the Human IGFBP3 Promoter and Potential Implication of Adjacent Single-Nucleotide Polymorphisms and Responsiveness to Insulin Endocrinology, December 1, 2007; 148(12): 6007 - 6018. [Abstract] [Full Text] [PDF]

				Q. Shen, D. D. Lantvit, Q. Lin, Y. Li, K. Christov, Z. Wang, T. G. Unterman, R. G. Mehta, and S. M. Swanson Advanced Rat Mammary Cancers Are Growth Hormone Dependent Endocrinology, October 1, 2007; 148(10): 4536 - 4544. [Abstract] [Full Text] [PDF]

				E. S Schernhammer, S. S Tworoger, A H. Eliassen, S. A Missmer, J. M Holly, M. N Pollak, and S. E Hankinson Body shape throughout life and correlations with IGFs and GH Endocr. Relat. Cancer, September 1, 2007; 14(3): 721 - 732. [Abstract] [Full Text] [PDF]

				Y. Bremnes, G. Ursin, N. Bjurstam, S. Rinaldi, R. Kaaks, and I. T. Gram Insulin-like Growth Factor and Mammographic Density in Postmenopausal Norwegian Women Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 57 - 62. [Abstract] [Full Text] [PDF]